ロード中...
Brain metastases in ALK-positive NSCLC – time to adjust current treatment algorithms
The progress in molecular biology has revolutionized systemic treatment of advanced non-small-cell lung cancer (NSCLC) from conventional chemotherapy to a treatment stratified by histology and genetic aberrations. Tumors harboring a translocation of the anaplastic-lymphoma-kinase (ALK) gene constitu...
保存先:
| 出版年: | Oncotarget |
|---|---|
| 主要な著者: | , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Impact Journals LLC
2018
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6205553/ https://ncbi.nlm.nih.gov/pubmed/30416687 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.26073 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|